Revive Therapeutics Ltd (RVVTF)

[MrJenkins24]

Not sure all the panic coming from people. Conducting clinical trials isn't free. Here's an excerpt from Fidelity's article:

The net proceeds of the Offering will be used by the Company for Phase 3 ?clinical costs for Bucillamine for COVID-19, Phase 1 clinical ?costs for Psilocybin for methamphetamine use disorder ?study, and other Psychedelic formulation development work as well as working capital and general corporate purposes.

Next, the two companies underwriting the deal each have around $2 billion in assets. One would think you'd be excited two, multi-billion dollar investment firms see value in RVV and invested in what should be a bright future.